000 01462 a2200337 4500
005 20250516152529.0
264 0 _c20151103
008 201511s 0 0 eng d
022 _a1548-8756
024 7 _a10.14694/EdBook_AM.2013.33.e295
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJuergens, Rosalyn A
245 0 0 _aAberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.
_h[electronic resource]
260 _bAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
_c2013
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review; Video-Audio Media
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aCell Transformation, Neoplastic
_xgenetics
650 0 4 _aDrug Design
650 0 4 _aEpigenesis, Genetic
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aPhenotype
700 1 _aRudin, Charles M
773 0 _tAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
856 4 0 _uhttps://doi.org/10.14694/EdBook_AM.2013.33.e295
_zAvailable from publisher's website
999 _c22787069
_d22787069